Apelin: A novel marker for the patients with first ST-elevation myocardial infarction

Heart and Vessels

Volumn 25, Issue 5, 2010, Pages 363-367

  Kuklinska, Agnieszka M ^a   Sobkowicz, Bozena ^a   Sawicki, Robert ^a   Musial, Wlodzimierz J ^a   Waszkiewicz, Ewa ^a   Bolinska, Swietlana ^a   Małyszko, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apelin; ST elevation myocardial infarction

Indexed keywords

APELIN;

AGED; ARTICLE; BLOOD LEVEL; DEATH; FEMALE; FOLLOW UP; HEART INJURY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PATIENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL ANALYSIS; STROKE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; POLAND; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STROKE; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77956025259     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1217-3     Document Type: Article

References (21)

1. B. Chandrasekaran O. Dar T. McDonagh 2008 The role of apelin in cardiovascular function and heart failure Eur J Heart Fail 10 725 732 10.1016/j.ejheart.2008.06.002 1:CAS:528:DC%2BD1cXoslWktL0%3D 18583184
2. K.S. Chong R.S. Gardner J.J. Morton E.A. Ashley T.A. McDonagh 2006 Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure Eur J Heart Fail 8 355 360 10.1016/j.ejheart.2005.10.007 1:CAS:528:DC%2BD28Xls1eiu78%3D 16464638
3. N. De Mota A. Reaux-Le Goazigo S. El-Messari N. Chartrel D. Roesch C. Dujardin C. Kordon H. Vaudry F. Moos C. Llorens-Cortes 2004 Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release Proc Natl Acad Sci USA 101 10464 10469 10.1073/pnas.0403518101 15231996
4. V.P. Ronkainen J.J. Ronkainen S.L. Hänninen H. Leskinen J.L. Ruas T. Pereira L. Poellinger O. Vuolteenaho P. Tavi 2007 Hypoxia inducible factor regulates the cardiac expression and secretion of apelin FASEB J 21 1821 1830 10.1096/fj.06-7294com 1:CAS:528:DC%2BD2sXmsVWksrY%3D 17341685
5. J.P. Goetze J.F. Rehfeld J. Carlsen R. Videbaek C.B. Andersen S. Boesgaard L. Friis-Hansen 2006 Apelin: a new plasma marker of cardiopulmonary disease Regul Pept 133 134 138 10.1016/j.regpep.2005.09.032 1:CAS:528: DC%2BD2MXhtlCqtLzE 16263185
6. N. Dagli U. Ozturk I. Karaca M. Yavuzkir S. Koca H. Akbulut M. Balin 2009 Adiponectin levels in coronary artery ectasia Heart Vessels 24 84 89 10.1007/s00380-008-1087-0 19337790
7. H. Selcuk M.T. Selcuk A. Temizhan O. Maden G.S. Saydam H. Ulupinar M. Dogan C. Aydin D.I. Topcu A. Sasmaz 2009 Decreased plasma concentrations of adiponectin in patients with slow coronary flow Heart Vessels 24 1 7 10.1007/s00380-008-1074-5 19165561
8. M.F. Berry T.J. Pirolli V. Jayasankar J. Burdick K.J. Morine T.J. Gardner Y.J. Woo 2004 Apelin has in vivo inotropic effects on normal and failing hearts Circulation 110 11suppl1 II187 II193 15364861
9. A.G. Japp N.L. Cruden D.A. Amer V.K. Li E.B. Goudie N.R. Johnston S. Sharma I. Neilson D.J. Webb I.L. Megson A.D. Flapan D.E. Newby 2008 Vascular effects of apelin in vivo in man J Am Coll Cardiol 52 908 913 10.1016/j.jacc.2008.06.013 1:CAS:528:DC%2BD1cXhtVyjsbnE 18772060
10. R.A. Weir K.S. Chong J.R. Dalzell C.J. Petrie C.A. Murphy T. Steedman P.B. Mark T.A. McDonagh H.J. Dargie J.J. McMurray 2009 Plasma apelin concentration is depressed following acute myocardial infarction in man Eur J Heart Fail 11 551 558 10.1093/eurjhf/hfp043 1:CAS:528:DC%2BD1MXms12ht7Y%3D 19351633
11. K.H. Miettinen J. Magga O. Vuoltenaho E.J. Vanninen K.R. Punnonen K. Ylitalo P. Tuomainen K.J. Peuhkurinen 2007 Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy Regul Pept 140 178 184 10.1016/j.regpep.2006.12.004 1:CAS:528:DC%2BD2sXjsVensr0%3D 17223209
12. M. Codognotto A. Piccoli M. Zaninotto M. Mion U. Vertolli F. Tona G.M. Boffa 2007 Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy Am J Nephrol 27 1 6 10.1159/000098430 1:CAS:528:DC%2BD2sXisFyhu7k%3D 17204831
13. J. Malyszko J.S. Malyszko P. Kozminski M. Mysliwiec 2006 Apelin and cardiac function in hemodialyzed patients: possible relations? Am J Nephrol 26 121 126 10.1159/000092122 1:CAS:528:DC%2BD28XltFWltLc%3D 16549903
14. M.M. Chen E.A. Ashley D.X. Deng A. Tsalenko A. Deng R. Tabibiazar A. Ben-Dor B. Fenster E. Yang J.Y. King M. Fowler R. Robbins F.L. Johnson L. Bruhn T. McDonagh H. Dargie Z. Yakhini P.S. Tsao T. Quertermous 2003 Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction Circulation 108 1432 1439 10.1161/01.CIR.0000091235.94914.75 1:CAS:528:DC%2BD3sXntlarur0%3D 12963638
15. P. Francia A. Salvati C. Balla P. De Paolis E. Pagannone M. Borro G. Gentile M. Simmaco L. De Biase M. Volpe 2007 Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin Eur J Heart Fail 9 306 309 10.1016/j.ejheart.2006.06.005 1:CAS:528:DC%2BD2sXitl2nsLk%3D 16891152
16. J. Simpkin D.M. Yellon S.M. Davidson S.Y. Lim A.M. Wynne C.C.T. Smith 2007 Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury Basic Res Cardiol 102 518 528 10.1007/s00395-007- 0671-2 1:CAS:528:DC%2BD2sXhtlCnsrnK 17694254
17. P. Atluri K.J. Morine G.P. Liao C.M. Panlilio M.F. Berry V.M. Hsu W. Hiesinger J.E. Cohen Y. Joseph Woo 2007 Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression Cell Mol Biol Lett 12 127 138 10.2478/s11658-006-0058-7 1:CAS:528:DC%2BD2sXpslensb0%3D 17119870
18. A.Y. Sheikh H.J. Chun A.J. Glassford R.K. Kundu I. Kutschka D. Ardigo S.L. Hendry R.A. Wagner M.M. Chen Z.A. Ali P. Yue D.T. Huynh A.J. Connolly M.P. Pelletier P.S. Tsao R.C. Robbins T. Quertermous 2008 In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure Am J Physiol Heart Circ Physiol 294 H88 H98 10.1152/ajpheart.00935.2007 1:CAS:528: DC%2BD1cXhtVKisb4%3D 17906101
19. Z. Li Y. Bai J. Hu 2008 Reduced apelin levels in stable angina Intern Med 47 1951 1955 10.2169/internalmedicine.47.1287 19015606
20. Y.X. Jia C.S. Pan J. Zhang B. Geng J. Zhao H. Gerns J. Yang J.K. Chang C.S. Tang Y.F. Qi 2006 Apelin protects myocardial injury induced by isoproterenol in rats Regul Pept 133 147 154 10.1016/j.regpep.2005.09.033 1:CAS:528:DC%2BD2MXhtlCqtL3M 16278022
21. C.C. Smith M.M. Mocanu J. Bowen A.M. Wynne J.C. Simpkin R.A. Dixon M.B. Cooper D.M. Yellon 2007 Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin Cardiovasc Drugs Ther 21 409 414 10.1007/s10557-007-6054-y 1:CAS:528:DC%2BD2sXhtl2ks7zJ 17924178